iris
Well-known Member
Having used exclusively pharma for years when possible, and never venturing into UGL clen in my life (doubtful I’ll start):
I don’t think our brains get even passing marks at rooting out causation and trends from self-selectively biased data like these; and I basically trust jano nigh absolutely on this matter.
He communicates to us clearly here that it’s evident to him — he who is best positioned to make this kind of assessment — that UGL and pharma alike are capable of both brilliant accuracy and egregious mistake (off by a factor of 10,000 as it were in the case of 50 mg clen).
I can’t go back and interpret this data because it’s impracticable for me to do so. I have a lot of raw reports, like, hundreds I’m sure, that I have in my Proton Drive from guys’ sending em to me. Scruf did tremendous work in this regard and people are always testing. But jano personally signs off on 2,000 a week?
I can’t make heads or tails of trends besides saying QSC is clearly a pharma company…
Jano does this professionally. Quant. analytical chemistry. It’s his business, not I daresay, ours
Not doubting him, at all.
I don't think, here, anyone is.
I was just trying to make sense of what I actually saw and how I think/feel about it, in relation to what he said, that's all.
In the end, even with data at hand, the bias you refer to may remain.
Some people will prefer sticking with pharma for certain things, no matter what.
For the ones that don't care for it and want to use ugl, at least they know (thanks to his involvement) that the quality and safety profile of their oral production has improved, greatly.